| AURA |
Aura Biosciences, Inc. |
Common Stock, par value $0.00001 per share |
11% |
$38,214,242 |
|
6,922,870 |
|
Matrix Capital Management Company LP |
16 May 2025 |
| PRM |
Perimeter Solutions, Inc. |
Common stock, par value $0.0001 per share |
4.5% |
$66,850,800 |
|
6,554,000 |
|
Matrix Capital Management Company LP |
31 Dec 2024 |
| MAZE |
Maze Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
3.5% |
$42,880,026 |
-$21,586,725 |
1,653,684 |
-33% |
Matrix Capital Management Company, LP |
30 Sep 2025 |
| ADAP |
Adaptimmune Therapeutics plc |
Ordinary Shares, par value 0.001 GBP per share |
0% |
$0 |
-$36,450,000 |
0 |
-100% |
Matrix Capital Management Company LP |
31 Dec 2024 |
| ALTR |
Altair Engineering Inc. |
Class A Common Stock, $0.0001 par value per share |
0% |
$0 |
|
0 |
|
Matrix Capital Management Company, LP |
31 Mar 2025 |
| ZNTL |
Zentalis Pharmaceuticals, Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
-$9,689,960 |
0 |
-100% |
Matrix Capital Management Company, LP |
30 Dec 2025 |